XML 148 R136.htm IDEA: XBRL DOCUMENT v3.25.0.1
Parent Company Financial Information (Condensed Statements of Cash Flows) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Condensed Financial Statements Captions Line Items      
Net (loss) income $ (41,646) $ 50,264 $ 56,573
Net gain on sale of assets of subsidiary (13,658) 0 0
Provision for litigation settlement 23,022 0 0
Provision for deferred taxes (35,348) (1,348) (4,382)
Depreciation and amortization 7,675 8,091 8,112
Share-based compensation 1,610 1,674 2,551
Decrease (increase) in other assets 20,470 (56,076) (29,902)
(Decrease) increase in other liabilities 13,216 372 80,580
Net cash provided by operating activities 77,127 10,894 133,573
Proceeds from sale of assets of subsidiary 27,000 0 0
Net cash used in investing activities (8,232) (310,090) (325,160)
Proceeds from issuance of common stock 108,572 0 0
Net cash (used in) provided by financing activities (106,016) 293,172 242,941
Net (decrease) increase in cash and cash equivalents (37,121) (6,024) 51,354
Cash and cash equivalents, beginning of period 124,442 130,466 79,112
Cash and cash equivalents, end of period 87,321 124,442 130,466
Parent Company [Member]      
Condensed Financial Statements Captions Line Items      
Net (loss) income (41,646) 50,264 56,573
Excess distributions of (equity in) undistributed earnings of subsidiary 52,570 (36,988) (29,673)
Net gain on sale of assets of subsidiary (13,658) 0 0
Provision for litigation settlement 23,022 0 0
Provision for deferred taxes (4,129) 95 216
Depreciation and amortization 73 76 77
Share-based compensation 1,610 1,674 2,551
Decrease (increase) in other assets 478 (494) (794)
(Decrease) increase in other liabilities (840) 111 7,478
Net cash provided by operating activities 17,480 14,738 36,428
Capital investment in subsidiaries (95,743) (1,893) (1,551)
Proceeds from sale of assets of subsidiary 27,000 0 0
Net cash used in investing activities (68,743) (1,893) (1,551)
Purchase of preferred and common shares (433) (571) (15,340)
Proceeds from issuance of common stock 108,572 0 0
Dividends paid (19,974) (19,745) (19,053)
Net cash (used in) provided by financing activities 88,165 (20,316) (34,393)
Net (decrease) increase in cash and cash equivalents 36,902 (7,471) 484
Cash and cash equivalents, beginning of period 16,331 23,802 23,318
Cash and cash equivalents, end of period $ 53,233 $ 16,331 $ 23,802